Fund Holdings — Novo Holdings A/S

Total Portfolio Value:
$1.49B
Total Bought:
$135.03M
Total Sold:
$244.66M
Net Transaction:
-$109.63M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Edgewise Therapeutics, Inc.(EWTX)5,350,0005,350,0000$217.37M$217.21M14.58%-$160.5K
Asml Holding N VN Y REGISTRY SHS
N Y REGISTRY SHS
94,94694,9460$188.89M$172.01M11.55%-$16.88M
Brookfield CorporationCL A(BN)3,496,2454,465,035+968,790$149.53M$162.80M10.93%+$13.26M
Hemab Therapeutics Hldgs Inc4,180,5504,180,5500$153.55M$128.93M8.65%-$24.62M
Avalyn Pharmaceuticals Inc3,883,2893,449,191-434,098$127.84M$98.27M6.60%-$29.57M
Mirum Pharmaceuticals, Inc.(MIRM)1,125,0001,125,0000$131.70M$96.17M6.46%-$35.54M
Salesforce, Inc.(CRM)393,187393,1870$61.60M$90.26M6.06%+$28.67M
Enliven Therapeutics Inc1,000,0001,000,0000$50.75M$45.84M3.08%-$4.91M
4d Molecular Therapeutics In3,249,1783,000,000-249,178$43.21M$42.93M2.88%-$284.1K
Obsidian Therapeutics Inc03,123,992+3,123,992$0$42.89M2.88%+$42.89M
Vaxcyte, Inc.(PCVX)800,000710,000-90,000$46.50M$40.40M2.71%-$6.11M
Floor & Decor Holdings, Inc.CL A(FND)797,000797,0000$47.31M$36.51M2.45%-$10.80M
Viridian Therapeutics, Inc.(VRDN)2,135,0001,750,000-385,000$39.22M$36.03M2.42%-$3.19M
Arrivent Biopharma Inc1,500,0001,175,000-325,000$52.11M$35.58M2.39%-$16.53M
Insmed Incorporated(INSM)120,723284,425+163,702$12.87M$32.46M2.18%+$19.59M
Pharvaris N V
COM
1,400,0001,019,426-380,574$48.41M$32.34M2.17%-$16.08M
Celldex Therapeutics, Inc.(CLDX)1,025,000950,000-75,000$38.14M$30.79M2.07%-$7.35M
Alibaba Group Holding LimitedADS(BABA)257,327257,3270$24.70M$27.67M1.86%+$2.97M
Xenon Pharmaceuticals Inc.(XENE)485,438652,105+166,667$29.30M$24.25M1.63%-$5.05M
Scholar Rock Holding Corporation(SRRK)0460,002+460,002$0$22.23M1.49%+$22.23M
Dyne Therapeutics, Inc.(DYN)960,3941,376,164+415,770$21.33M$22.17M1.49%+$839.7K
Maplight Therapeutics Inc3,686,6222,086,622-1,600,000$132.13M$21.26M1.43%-$110.87M
Contineum Therapeutics IncCL A0704,013+704,013$0$9.45M0.63%+$9.45M
Alumis Inc1,100,0001,250,000+150,000$30.95M$9.24M0.62%-$21.72M
Bridgebio Oncology Therapeut2,250,0002,250,0000$17.14M$9.22M0.62%-$7.92M
Marqeta, Inc.CL A(MQ)441,558110,389-331,169$7.17M$1.88M0.13%-$5.29M
Lanzatech Global Inc158,148158,1480$1.08M$903.0K0.06%-$175.5K
Crinetics Pharmaceuticals In1,320,0000-1,320,000$49.39M$0—-$49.39M
Page 1 of 1
Novo Holdings A/S — 13F Holdings — Q3 2026 | TickerTrail